Maximizing Hysteretic Losses in Magnetic Ferrite Nanoparticles Via Model-Driven Synthesis and Materials Optimization
Maximizing Hysteretic Losses in Magnetic Ferrite Nanoparticles Via Model-Driven Synthesis and Materials Optimization
Maximizing Hysteretic Losses in Magnetic Ferrite Nanoparticles Via Model-Driven Synthesis and Materials Optimization
ABSTRACT This article develops a set of design guidelines for maximizing heat
dissipation characteristics of magnetic ferrite MFe2O4 (M = Mn, Fe, Co) nano-
particles in alternating magnetic fields. Using magnetic and structural nanopar-
ticle characterization, we identify key synthetic parameters in the thermal
decomposition of organometallic precursors that yield optimized magnetic
nanoparticles over a wide range of sizes and compositions. The developed
synthetic procedures allow for gram-scale production of magnetic nanoparticles
stable in physiological buffer for several months. Our magnetic nanoparticles display some of the highest heat dissipation rates, which are in qualitative
agreement with the trends predicted by a dynamic hysteresis model of coherent magnetization reversal in single domain magnetic particles. By combining
physical simulations with robust scalable synthesis and materials characterization techniques, this work provides a pathway to a model-driven design of
magnetic nanoparticles tailored to a variety of biomedical applications ranging from cancer hyperthermia to remote control of gene expression.
T
he ability to tune the materials intended to limit nonspecific heating of
properties of magnetic nanoparticles healthy tissue via eddy currents induced
(MNPs) composed of spinel ferrites by the applied AMF.9 As a result, the field
MFe2O4 (M = Mn, Fe, Co) enables a variety parameters are usually limited to ampli-
of biomedical applications.13 For example, tudes 520 kA m1 and frequencies below
achieving a high magnetic moment is es- 1 MHz. To achieve the desired therapeutic
sential for effective magnetic resonance effect under the field frequency product
imaging (MRI) contrast agents, while max- constraint, the MNP power dissipation rate
imizing power dissipation in alternating per gram, or specific loss power (SLP), has to
magnetic fields (AMF) is desirable for heat- be optimized. Because the hysteresis losses
induced necrosis of tumor tissues.4,5 Recent in MNPs depend on their saturation magne-
work demonstrating fine control over the size, tization (Ms) and the effective anisotropy
shape, composition, and surface passivation energy barrier, these two parameters can
of superparamagnetic MNPs has propelled be varied for SLP optimization for an AMF of
the latter method, magnetic hyperthermia, a given amplitude and frequency. Guided
into clinical trials.6 AMF-induced heat dissipa- by the physical model of coherent magne-
tion in MNPs has also found new applications tization reversal in single domain MNPs, this * Address correspondence to
[email protected].
in remote control of cellular signaling and article correlates the structural and mag-
gene transcription in vivo.7,8 netic properties of ferrite MNPs (MFe2O4, Received for review July 10, 2013
For therapeutic purposes, the MNPs must M = Mn, Fe, Co) to key synthetic parameters and accepted September 9, 2013.
be administered at the lowest concentra- that determine the MNP performance as
Published online September 09, 2013
tions possible, and the product of AMF heat dissipation agents.10,11 The synthetic 10.1021/nn4035266
frequency f and amplitude Ho should be procedures developed within this study are
less than 5 109 A m1 s1, a figure of merit easily scalable to production of gram scale C 2013 American Chemical Society
only requires the addition of oleic acid and the reaction buffered saline (PBS) which has been attributed to the
conditions may not be sufficiently oxidizing to form formation of salt bridges (Figure S5).39
ferrimagnetic spinel phases. Interestingly, we find that the magnetic properties
High Temperature Phase Transfer of MNPs into Aqueous of the MNPs prepared by the thermal decomposition
Solutions. While high temperature thermolysis of orga- of metaloleate precurors are significantly improved
nometallic precursors produces monodisperse MNPs during the phase transfer process. For iron oxide MNPs,
with controllable shape and size, the surface is gen- Ms values increase from 15 to 40 emu g1 to an average
erally coated with hydrophobic ligands, which make of 67 emu g1, which is comparable to bulk values
them unusable for biological applications in aqueous of magnetite (92 emu g1, Figure 4A). Furthermore, the
environments. To render the nanocrystals hydrophilic, coercive field decreases from 1350 to 350 Oe and there
we employ high-temperature phase transfer in diethy- is no observable exchange bias (Figure 5C). The mag-
lene glycol, a high boiling point polar solvent miscible netic diameters are also found to correlate closely
with organic solvents such as toluene, to drive the with the physical MNP diameters determined by TEM,
coordination of poly(acrylic acid) (PAA) onto the surface and the ferromagnetic volume fraction exceeds 60%
of the MNPs at temperatures greater than 200 °C.38 This (Table 1). These improvements in the magnetic proper-
strategy is advantageous because the high tempera- ties can be attributed to the conversion of the wüstite
ture promotes the exchange of the original surfactant phase into a ferrimagnetic spinel phase. The high
with the polyelectrolyte through mass action. Further- temperature phase transfer step provides an oxidizing
more, the multiple binding sites prevent PAA desorp- environment that enables the transformation of
tion, while allowing its extension into water to make the metastable wüstite into maghemite and magnetite
nanocrystals highly soluble in aqueous media. Ligand phases, with no evidence of FeO peaks apparent in
exchange with PAA resulted in the MNPs to be highly the powder diffraction pattern (Figure 6B). Our data
stable in Good's buffers such as tris(hydroxymethyl)- are in agreement with prior reports that observe the
aminomethane (Tris) and (4-(2-hydroxyethyl)-1- conversion of wüstite MNPs into Fe3O4 and γ-Fe2O4
piperazineethanesulfonic acid) (HEPES), although time- during annealing in air at temperatures between
dependent aggregation was observed in phosphate 140 200 °C.35
MATERIALS AND METHODS complex and 2.5 mmol of oleic acid were dissolved in 25 mL of
1-octadecene in a 250 mL 3-neck flask and evacuated for 30 min.
Sodium oleate was purchased from TCI America. All other
Then the solution was heated to 200 °C under nitrogen flow,
solvents and reagents were purchased from Sigma-Aldrich and
used without further purification. further heated to 310 °C at a rate of 1 °C/min, and held at the
specified temperature for 1 h. After the heating mantle was
Preparation of MetalOleate Complex. The metaloleate
MFe2(C18H33O2)8 precursor (where M = Fe, Co, Mn) was pre- removed and the solution was cooled to room temperature, an
pared by reacting sodium oleate and the respective metal entire reaction solution was transferred into a 50 mL conical tube
chloride salt.19,21 We scaled our preparation such that the total along with a 1:1 mixture of ethanol and hexane. The sample was
metal content was 60 mmol per reaction. For example, an iron centrifuged at 6000 rpm for 10 min to collect the synthesized
cobalt metal complex CoFe2(C18H33O2)8 was prepared by dis- nanocrystals. The pelleted nanocrystals were redispersed in
solving 40 mmol of FeCl3, 20 mmol of CoCl2, and 160 mmol of 10 mL of hexane, flocculated with 5 mL of ethanol, and centri-
sodium oleate in 100 mL of ethanol, 100 mL of Milli-Q water, and fuged at 6000 rpm for 10 min twice to remove excess ligand
200 mL of hexane and heated to reflux at 60 °C for 4 h. After and solvent. The nanocrystals were then dispersed in toluene.
removal of the aqueous phase, the organic phase was heated to MNPs (10, 18, and 23 nm) were synthesized by setting the final
70 °C for 2 h and then placed under vacuum at 110 °C for an temperature to 305, 320, and 325 °C, respectively. Twenty-six
additional 2 h to remove residual solvent, leaving behind a nanometer MNPs were prepared by setting the final temperature
viscous metaloleate product. to 330 °C in 25 mL of 1-eicosene.
Synthesis of Monodisperse and Spherical MFe2O4 Nanocrystals of To synthesize MnFe2O4 15 nm MNPs, 5 mmol of the
Different Sizes from MetalOleate Precursors. To synthesize 15 nm metaloleate complex and 2.5 mmol of oleic acid were dis-
in diameter iron oxide nanoparticles, 5 mmol of the metaloleate solved in 10 mL of 1-octadecene in a 250 mL 3-neck flask and